EVALUATION OF ORVIL ANASTOMOSIS TECHNOLOGY IN ESOPHAGEAL CANCER SURGERY: IMPLICATIONS FOR POSTOPERATIVE RECOVERY AND PHYSICAL REHABILITATION OUTCOMES
Keywords:
Anastomotic Technology of the Transoral Anvil Conveying System; Esophageal Cancer; SafetyAbstract
Objective: To evaluate the application and safety of the Through-Mouth Nail Anvil Head Conveying System (Orvil) anastomosis technology in esophageal cancer treatment and its implications for postoperative recovery and physical rehabilitation. Methods: A retrospective analysis was conducted on 91 esophageal cancer patients treated with Orvil anastomosis technology between 2019 and 2022 (research group) and compared with 52 patients treated with traditional anastomosis between 2011 and 2013 (control group). Key surgical indicators, lymph node dissection, and postoperative safety outcomes were analyzed, with a focus on factors influencing physical recovery and rehabilitation potential. Results: There was no significant difference in gender or TNM staging between the groups (P > 0.05), but significant differences were observed in age and tumor location (P < 0.05). The research group experienced significantly shorter operation and hospitalization times and reduced total postoperative drainage volume compared to the control group (P < 0.05). However, chest tube indwelling time was longer in the research group (P < 0.05). Intraoperative blood loss and postoperative discharge time did not differ significantly between groups (P > 0.05). The research group had a significantly higher number of lymph node dissections (P < 0.05), while the number of positive lymph nodes was similar (P > 0.05). Complications in the research group included recurrent laryngeal nerve injury (1.10%), chylothorax (1.10%), anastomotic leakage (1.10%), respiratory complications (12.09%), and other complications (13.19%), with an overall complication rate of 28.57%. In the control group, the overall complication rate was 21.15%, with no statistically significant difference between the groups (P > 0.05). Conclusion: Orvil anastomosis technology is a feasible and relatively safe surgical approach for esophageal cancer, offering significant advantages in shorter operation and hospitalization times, reduced postoperative drainage, and more thorough lymph node dissection. These benefits contribute to enhanced early postoperative recovery, potentially improving patients' ability to engage in physical rehabilitation and maintain functional capacity. Further research should explore the long-term impacts of this technology on physical activity and overall quality of life, particularly in the context of sports and exercise rehabilitation programs.